Canada’s TMX Group in Talks to Buy Cboe Australia, AFR Says

TMX Group has emerged as the preferred bidder to buy Cboe Global Markets’ Australian unit, according to the AFR, after lengthy talks and discussions with the Australian Securities and Investments Commission. The deal would provide more certainty around the future of Australia’s second-largest exchange operator. Advisers on the transaction are Macquarie Capital for TMX and Barclays for Cboe.

Analysis

This is less about a single asset sale than about control of market infrastructure in a fragmented, regulation-heavy venue business. If TMX wins, the strategic value is that it can bolt on an offshore exchange with relatively low capex and potentially improve earnings quality through data, listings, and market-services cross-sell; that is why X.TO should trade more on optionality than on near-term deal economics. The key second-order benefit is to TMX’s negotiating power with issuers and brokers across its broader network, because ownership of a non-domestic venue can strengthen its pitch as a multi-jurisdiction execution and listing partner.

For CBOE, the Australian unit is likely a modest earnings contributor but a meaningful distraction from the core franchise if regulatory oversight becomes prolonged. The market may be underestimating the value of removing a small, lower-growth asset that is more trouble than it is worth; however, any sale process also risks reinforcing the idea that management is pruning around the edges rather than deploying capital into higher-return buybacks or product innovation. Barclays is mostly insulated, but any extended process implies advisory fees are contingent on deal completion timing, not just announced talks.

The main catalyst path is regulatory, not commercial: ASIC approval and any competition review can stretch from weeks into months, and that timing matters more than headline price. The tail risk is that a foreign buyer draws political scrutiny if the exchange is seen as systemically important, which would compress probability of close and force TMX to walk away or reprice. Conversely, if the market starts pricing a cleaner close, TMX could see a modest rerating on the signal of disciplined M&A execution rather than transformational earnings accretion.

Consensus likely assumes this is a small, low-signal transaction; that misses the governance angle. In exchange businesses, control of market plumbing and data distribution often matters more than immediate EBITDA, so even a minor acquisition can have outsized strategic value if it improves venue stickiness and regulatory credibility. The underappreciated risk is that if TMX overpays for a non-core offshore asset, it could cap multiple expansion by raising questions about capital allocation discipline.

Key Decisions for Investors

• Long X.TO on a 1-3 month horizon if confirmation of regulatory progress emerges; target a modest rerating from strategic optionality, with downside limited if the deal stalls and management remains cash-generative.
• Use CBOE weakness to add on any post-rumor pullback: the Australian unit is not the core value driver, so even if the sale slips, the risk/reward favors the parent retaining capital for buybacks and higher-return uses.
• Pair trade: long X.TO / short CBOE for 4-8 weeks if the market starts to price a cleaner close; thesis is that TMX gets strategic scarcity value while CBOE’s headline dilution narrative keeps a lid on upside.
• Avoid chasing BCS on this headline; advisory economics are too small and too contingent to justify a standalone position unless broader capital-markets M&A volumes improve.